Our analyses revealed a consistent increase in multiple inflammatory interleukins—specifically IL-1RA, IL-6, IL-8, IL-10, and IL-17A—in the plasma of early-stage NSCLC patients and xenograft-bearing mice compared with controls. This evidence concerns the gene IL6 and non-small cell lung carcinoma.